|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.15 CNY | +3.62% |
|
+2.79% | -27.67% |
Beijing Beilu Pharmaceutical Co., Ltd reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 557.31 million compared to CNY 680.84 million a year ago. Revenue was CNY 557.31 million compared to CNY 680.84 million a year ago.
Net income was CNY 55.23 million compared to CNY 129.74 million a year ago. Basic earnings per share from continuing operations was CNY 0.1126 compared to CNY 0.2653 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -27.67% | 350M | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| -5.52% | 206B | |
| +6.17% | 164B | |
| -0.45% | 162B |
BEIJING BEILU PHARMACEUTICAL CO., LTD 
